Lyrecol 5 % 5 % w/v Medicated Nail Lacquer

    Lyrecol 5 % 5 % w/v Medicated Nail Lacquer

    S1
    PDF Leaflet Revision Date: 19 September 2023


    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Treatment of onychomycoses caused by dermatophytes, yeasts, and moulds.

    Dosage (summary)

    Apply once or twice weekly to affected nails.

    Special Populations

    • Elderly
    • Paediatric population

    Pregnancy & Breastfeeding

    Avoid use during pregnancy and breastfeeding due to lack of experience.

    Contraindications

    • Hypersensitivity to amorolfine or excipients

    Common side effects

    • Hypersensitivity
    • Skin burning sensation
    • Nail discolouration
    • Broken nails
    • Brittle nails

    Counselling Points

    • File down affected nails before application.
    • Clean nails with alcohol swab before each application.
    • Do not apply on surrounding skin.

    Serious warnings

    • Avoid cosmetic lacquers or artificial nails during treatment.
    • Possible systemic or local allergic reactions.
    Important Disclaimer

    The Lyrecol 5 % 5 % w/v Medicated Nail Lacquer professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn